These enzymes protect cells from oxidative damage, a major contributor to aging and disease
FOXO4-DRI is a senolytic peptide a D-retro-inverso peptide engineered to selectively eliminate senescent "zombie" cells that accumulate with age and secrete inflammatory factors (the senescence-associated secretory phenotype, or SASP)
Schedule your consultation today.
Unlike DAC-modified CJC-1295, CJC-1295 No DAC was developed to produce a more physiologic, short-duration stimulation of the GHRH receptor , making it well suited for studies focused on natural pulsatile GH release rather than prolonged receptor activation
The criteria for safety and efficacy testing are much less stringent with natural supplements
It is not recommended for use in pregnant women, breastfeeding women, infants, children and adolescents unless specifically advised by the doctor